Table of Content

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number Chronic Disease Testing
4.1.1.2. Research Activities
4.1.2. Restraints:
4.1.2.1. High cost of Instruments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Fluorescence Activated Cell Sorting (FACS)*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Magnetic Activated Cell Sorting (MACS)
7.4. Micro-Electromechanical Microfluidics Systems (MEMS)
7.5. Density Gradient Centrifugation
7.6. Immunodensity Cell Separation
7.7. Sedimentation
7.8. Others
8. By Product and Services
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Services
8.1.2. Market Attractiveness Index, By Product and Services
8.2. Cell Sorters*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Cell Sorting Reagents & Consumables
8.4. Cell Sorting Services
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Clinical Applications*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Research Applications
9.3.1. Immunology & Cancer Research
9.3.2. Stem Cell Research
9.3.3. Drug Discovery
9.3.4. Other Research Applications
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Research Institutes*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Pharmaceutical & Biotechnology Companies
10.4. Hospitals and Clinical Testing Laboratories
10.5. Medical Schools and Academic Institutions
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. Europe
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product and Services
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. Germany
11.2.7.2. U.K.
11.2.7.3. France
11.2.7.4. Italy
11.2.7.5. Spain
11.2.7.6. Rest of Europe
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Type Benchmarking
13. Company Profiles
13.1. Bio-Rad Laboratories, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Sony Biotechnology Inc.
13.3. Becton, Dickinson and Company
13.4. Merck KGaA
13.5. Danaher Corporation
13.6. Miltenyi Biotec GmbH
13.7. Affymetrix, Inc
13.8. Sysmex Partec GmbH
13.9. Union Biometrica, Inc.
13.10. pluriSelect Life Science UG & Co. KG
LIST NOT EXHAUSTIVE
14. Europe Cell Sorting Market – DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us